Livforsakringsbolaget Skandia, Omsesidigt Eli Lilly & CO Transaction History

Livforsakringsbolaget Skandia, Omsesidigt

$1.72 Billion
Q3 2024

A detailed history of Livforsakringsbolaget Skandia, Omsesidigt transactions in Eli Lilly & CO stock. As of the latest transaction made, Livforsakringsbolaget Skandia, Omsesidigt holds 29,176 shares of LLY stock, worth $22.4 Million. This represents 1.5% of its overall portfolio holdings.

Number of Shares

29,176

Previous 19,182 52.1%

Holding current value

$22.4 Million

Previous $17.4 Million 48.84%

% of portfolio

1.5%

Previous 1.42%

25 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 10, 2024	BUY	$772.14 - $960.02 $7.72 Million - $9.59 Million	9,994 Added 52.1%	29,176 $25.8 Million
Q2 2024 Jul 15, 2024	BUY	$724.87 - $909.04 $710,372 - $890,859	980 Added 5.38%	19,182 $17.4 Million
Q1 2024 Apr 23, 2024	BUY	$592.2 - $792.28 $1.72 Million - $2.3 Million	2,900 Added 18.95%	18,202 $14.2 Million
Q4 2023 Jan 31, 2024	BUY	$525.19 - $619.13 $282,027 - $332,472	537 Added 3.64%	15,302 $8.92 Million
Q3 2023 Oct 20, 2023	SELL	$434.7 - $599.3 $282,555 - $389,544	-650 Reduced 4.22%	14,765 $7.93 Million
Q2 2023 Jul 06, 2023	SELL	$350.74 - $468.98 $526,110 - $703,470	-1,500 Reduced 8.87%	15,415 $7.23 Million
Q4 2022 Feb 13, 2023	SELL	$321.55 - $374.67 $3.41 Million - $3.97 Million	-10,600 Reduced 38.52%	16,915 $6.19 Million
Q3 2022 Nov 14, 2022	SELL	$296.48 - $337.87 $4.87 Million - $5.55 Million	-16,440 Reduced 37.4%	27,515 $8.9 Million
Q2 2022 Aug 16, 2022	SELL	$278.73 - $327.27 $2.8 Million - $3.29 Million	-10,050 Reduced 18.61%	43,955 $14.3 Million
Q4 2021 Feb 14, 2022	SELL	$224.85 - $279.04 $786,975 - $976,640	-3,500 Reduced 6.09%	54,005 $14.9 Million
Q3 2021 Oct 28, 2021	SELL	$221.6 - $272.71 $531,840 - $654,504	-2,400 Reduced 4.01%	57,505 $13.3 Million
Q2 2021 Jul 13, 2021	BUY	$180.55 - $233.54 $595,815 - $770,682	3,300 Added 5.83%	59,905 $13.8 Million
Q1 2021 May 07, 2021	BUY	$164.32 - $212.72 $1.13 Million - $1.47 Million	6,900 Added 13.88%	56,605 $10.6 Million
Q4 2020 Mar 02, 2021	BUY	$130.46 - $172.63 $482,702 - $638,731	3,700 Added 8.04%	49,705 $8.39 Million
Q3 2020 Nov 09, 2020	BUY	$146.22 - $169.13 $342,154 - $395,764	2,340 Added 5.36%	46,005 $6.81 Million
Q2 2020 Jul 08, 2020	BUY	$136.42 - $164.18 $968,581 - $1.17 Million	7,100 Added 19.42%	43,665 $7.17 Million
Q1 2020 Apr 22, 2020	BUY	$119.05 - $147.35 $309,530 - $383,110	2,600 Added 7.65%	36,565 $5.07 Million
Q4 2019 Jan 28, 2020	SELL	$106.92 - $132.43 $406,296 - $503,234	-3,800 Reduced 10.06%	33,965 $4.46 Million
Q3 2019 Oct 29, 2019	BUY	$106.79 - $116.16 $1.9 Million - $2.07 Million	17,800 Added 89.16%	37,765 $4.22 Million
Q2 2019 Jul 19, 2019	BUY	$110.79 - $129.32 $1.16 Million - $1.36 Million	10,500 Added 110.94%	19,965 $2.21 Million
Q1 2019 May 09, 2019	SELL	$111.31 - $131.02 $996,447 - $1.17 Million	-8,952 Reduced 48.61%	9,465 $1.23 Million
Q3 2018 Oct 26, 2018	SELL	$85.86 - $107.31 $918,702 - $1.15 Million	-10,700 Reduced 36.75%	18,417 $1.98 Million
Q2 2018 Jul 10, 2018	BUY	$75.7 - $86.88 $181,680 - $208,512	2,400 Added 8.98%	29,117 $2.49 Million
Q4 2017 Jan 18, 2018	SELL	$81.94 - $87.89 $385,118 - $413,083	-4,700 Reduced 14.96%	26,717 $2.26 Million
Q3 2017 Oct 12, 2017	BUY	$77.07 - $85.54 $2.42 Million - $2.69 Million	31,417	31,417 $2.69 Million

Others Institutions Holding LLY

# of Institutions

4,011

Shares Held

751M

Call Options Held

8.27M

Put Options Held

10.5M

View Full List

About ELI LILLY & Co

Ticker LLY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 950,174,976
Market Cap $730B
Description
Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...

More about LLY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Livforsakringsbolaget Skandia, Omsesidigt, based on Form 13F filings with the SEC.

News

Stay updated on Livforsakringsbolaget Skandia, Omsesidigt with notifications on news.

Account

Livforsakringsbolaget Skandia, Omsesidigt Eli Lilly & CO Transaction History